Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)

This article was originally published in The Pink Sheet Daily

Executive Summary

Countering the rush out of Japan's discovery research sector, a few global pharmaceutical corporations are maintaining early research operations or even expanding their presence in this area.
Advertisement

Related Content

Discovery Research In Japan By Global Pharmaceutical Outfits: Evolving More Toward Partnerships? (Part 1 of 3)
Discovery Research In Japan By Global Pharmaceutical Outfits: Evolving More Toward Partnerships? (Part 1 of 3)
Chugai Releases New Actemra Data, Rides Wave To Submit U.S. FDA Response In Third Quarter
Pfizer To Become Largest Pharma In Japan After Wyeth Merger
Roche In Search Of Partnerships, Innovation In China Rather Than Outsourcing; Biologics Will Drive Innovation
Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
Novartis’ Paul Herrling And En Li On R&D Strategy In China, India And The Pacific Rim: An Interview With PharmAsia News (Part 1 of 2)
Takeda Makes $1 Billion Move For Amgen Development Rights

Topics

Advertisement
UsernamePublicRestriction

Register

PS069754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel